M. Helen Huls Division of Pediatrics U.T. MD Anderson Cancer Center Biography Publications Institution JoVE Articles M. Helen Huls has not added a biography. If you are M. Helen Huls and would like to personalize this page please email our Author Liaison for assistance. Publications Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells PloS One. 2012 | Pubmed ID: 22279576 Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients with Locoregional Nasopharyngeal Carcinoma Journal of Immunotherapy (Hagerstown, Md. : 1997). Nov-Dec, 2010 | Pubmed ID: 20948438 Enhancing the in Vivo Expansion of Adoptively Transferred EBV-specific CTL with Lymphodepleting CD45 Monoclonal Antibodies in NPC Patients Blood. Mar, 2009 | Pubmed ID: 18971421 Virus-specific T Cells Engineered to Coexpress Tumor-specific Receptors: Persistence and Antitumor Activity in Individuals with Neuroblastoma Nature Medicine. Nov, 2008 | Pubmed ID: 18978797 Complete Responses of Relapsed Lymphoma Following Genetic Modification of Tumor-antigen Presenting Cells and T-lymphocyte Transfer Blood. Oct, 2007 | Pubmed ID: 17609424 Monoculture-derived T Lymphocytes Specific for Multiple Viruses Expand and Produce Clinically Relevant Effects in Immunocompromised Individuals Nature Medicine. Oct, 2006 | Pubmed ID: 16998485 In Vivo Expansion of LMP 1- and 2-specific T-cells in a Patient Who Received Donor-derived EBV-specific T-cells After Allogeneic Stem Cell Transplantation Leukemia & Lymphoma. May, 2006 | Pubmed ID: 16753867 Administration of Latent Membrane Protein 2-specific Cytotoxic T Lymphocytes to Patients with Relapsed Epstein-Barr Virus-positive Lymphoma Clinical Lymphoma & Myeloma. Jan, 2006 | Pubmed ID: 16507214 Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV-positive Nasopharyngeal Carcinoma and Lymphoma Journal of Immunology (Baltimore, Md. : 1950). Sep, 2005 | Pubmed ID: 16148164 Treatment of Nasopharyngeal Carcinoma with Epstein-Barr Virus--specific T Lymphocytes Blood. Mar, 2005 | Pubmed ID: 15542583 Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease The Journal of Experimental Medicine. Dec, 2004 | Pubmed ID: 15611290 Treatment of Epstein-Barr Virus Lymphoproliferative Disease After Hematopoietic Stem-cell Transplantation with Hydroxyurea and Cytotoxic T-cell Lymphocytes Transplantation. Sep, 2004 | Pubmed ID: 15371682 The Generation and Characterization of LMP2-specific CTLs for Use As Adoptive Transfer from Patients with Relapsed EBV-positive Hodgkin Disease Journal of Immunotherapy (Hagerstown, Md. : 1997). Jul-Aug, 2004 | Pubmed ID: 15235393 Prompt Versus Preemptive Intervention for EBV Lymphoproliferative Disease Blood. May, 2004 | Pubmed ID: 14751931 A Strategy for Treatment of Epstein-Barr Virus-positive Hodgkin's Disease by Targeting Interleukin 12 to the Tumor Environment Using Tumor Antigen-specific T Cells Cancer Gene Therapy. Feb, 2004 | Pubmed ID: 14685154 Adoptive T-cell Therapy for Epstein-Barr Virus-positive Hodgkin's Disease Acta Haematologica. 2003 | Pubmed ID: 14583675 Journal of Immunotherapy (Hagerstown, Md. : 1997). May-Jun, 2003 | Pubmed ID: 12806278 Generating CTLs Against the Subdominant Epstein-Barr Virus LMP1 Antigen for the Adoptive Immunotherapy of EBV-associated Malignancies Blood. Mar, 2003 | Pubmed ID: 12411306 Autologous Epstein-Barr Virus (EBV)-specific Cytotoxic T Cells for the Treatment of Persistent Active EBV Infection Blood. Dec, 2002 | Pubmed ID: 12393655 Adapting a Transforming Growth Factor Beta-related Tumor Protection Strategy to Enhance Antitumor Immunity Blood. May, 2002 | Pubmed ID: 11964281 Generation of EBV-specific CD4+ Cytotoxic T Cells from Virus Naive Individuals Journal of Immunology (Baltimore, Md. : 1950). Jan, 2002 | Pubmed ID: 11777989 Автоматизированная Обогащение Ячейка Цитомегаловирус-специфические Т-клетки для клинического применения с использованием системы цитокинов захвата Pappanaicken Kumaresan*1, Mathew Figliola*1, Judy S. Moyes1, M. Helen Huls1, Priti Tewari1, Elizabeth J. Shpall2, Richard Champlin2, Laurence J.N. Cooper1 1Division of Pediatrics, U.T. MD Anderson Cancer Center, 2Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center Immunology and Infection Клиническое применение M. Helen Huls1, Matthew J. Figliola1, Margaret J. Dawson1, Simon Olivares1, Partow Kebriaei2, Elizabeth J. Shpall2, Richard E. Champlin2, Harjeet Singh1, Laurence J.N. Cooper1 1Division of Pediatrics, U.T. MD Anderson Cancer Center, 2Department of Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center JoVE 50070 Immunology and Infection
Автоматизированная Обогащение Ячейка Цитомегаловирус-специфические Т-клетки для клинического применения с использованием системы цитокинов захвата Pappanaicken Kumaresan*1, Mathew Figliola*1, Judy S. Moyes1, M. Helen Huls1, Priti Tewari1, Elizabeth J. Shpall2, Richard Champlin2, Laurence J.N. Cooper1 1Division of Pediatrics, U.T. MD Anderson Cancer Center, 2Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center Immunology and Infection
Клиническое применение M. Helen Huls1, Matthew J. Figliola1, Margaret J. Dawson1, Simon Olivares1, Partow Kebriaei2, Elizabeth J. Shpall2, Richard E. Champlin2, Harjeet Singh1, Laurence J.N. Cooper1 1Division of Pediatrics, U.T. MD Anderson Cancer Center, 2Department of Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center JoVE 50070 Immunology and Infection
